The ribonucleic acid (RNA) isolation and enrichment products market size is expected to see rapid growth in the next few years. It will grow to $10.54 billion in 2030 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to rising demand for precision medicine and personalized diagnostics, increasing adoption of next generation sequencing technologies, growth in single cell and spatial transcriptomics research, expansion of automated laboratory workflows and robotics integration, increasing investment in advanced biomarker discovery platforms. Major trends in the forecast period include increasing adoption of automated rna extraction platforms integrated with laboratory robotics, rising demand for high purity rna isolation kits for next generation sequencing workflows, growing use of magnetic bead based rna purification technologies for improved yield and efficiency, expansion of low input and single cell rna isolation solutions for advanced genomics research, increasing integration of rna isolation workflows in high throughput drug discovery and biomarker identification.
The rising genomics research activities are expected to propel the growth of the ribonucleic acid (RNA) isolation and enrichment products market going forward. Genomics research activities involve the study of genes, RNA sequencing, and molecular interactions to better understand disease biology, genetic variations, and therapeutic responses. These research activities are increasing due to the growing demand for precision medicine, which emphasizes the development of personalized treatments based on an individual's genetic profile. RNA isolation and enrichment products support genomics research by facilitating the extraction and purification of high-quality RNA for sequencing, transcriptomics, and gene expression analysis, thereby enhancing data accuracy and the reliability of downstream molecular studies. For instance, in July 2023, according to a report published by the American Society of Gene & Cell Therapy (ASGCT), a US-based professional membership organization, at the end of the first quarter (Q1) 2023, there were 247 gene therapies in Phase II, but this number rose by 5% to reach 260 by the end of the second quarter (Q2), reflecting growing genomics and genetic research activities. Therefore, the rising genomics research activities are driving the growth of the ribonucleic acid (RNA) isolation and enrichment products market.
Major companies operating in the ribonucleic acid (RNA) isolation and enrichment products market are concentrating on developing automated RNA purification technologies, including magnetic bead-based automated extraction systems, to enhance workflow efficiency, minimize manual handling errors, and support high-throughput nucleic acid processing in clinical and research laboratories. Magnetic bead-based automated extraction systems are laboratory instruments that utilize magnetic particles to isolate and purify nucleic acids from biological samples through automated processing workflows. For instance, in January 2023, QIAGEN N.V., a Netherlands-based biotechnology company, launched the EZ2 Connect MDx platform to improve automated nucleic acid extraction and purification efficiency in diagnostic laboratories through streamlined sample processing and high-quality RNA and DNA isolation workflows. The EZ2 Connect MDx platform offers fully automated magnetic bead-based nucleic acid extraction with integrated touchscreen functionality and preloaded protocols to simplify laboratory workflows.
In January 2023, ALS Limited, an Australia-based testing laboratory company, acquired Invitek Molecular GmbH for an undisclosed amount. Through this acquisition, ALS Limited intended to enhance its molecular diagnostics and life sciences capabilities, broaden its portfolio of sample preparation and nucleic acid extraction technologies, and strengthen its presence in the global biotechnology and clinical testing markets. Invitek Molecular GmbH is a Germany-based provider of nucleic acid isolation kits, molecular diagnostic reagents, sample preparation technologies, and automated purification solutions for research, clinical, and industrial applications.
Major companies operating in the ribonucleic acid (RNA) isolation and enrichment products market report are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Cytiva, Sartorius AG, Bio-Rad Laboratories Inc., QIAGEN N.V., Promega Corporation, Takara Bio Inc., MP Biomedicals LLC, Analytik Jena GmbH+Co. KG, Macherey-Nagel GmbH & Co. KG, New England Biolabs Inc., Zymo Research Corporation, Bioneer Corporation, Yeasen Biotechnology (Shanghai) Co. Ltd., TianGen Biotech (Beijing) Co. Ltd., Geneaid Biotech Ltd., HiMedia Laboratories Pvt. Ltd., Norgen Biotek Corp., Vazyme Biotech Co. Ltd., Illumina Inc., Pacific Biosciences of California Inc., 10x Genomics Inc., Revvity Inc., LGC Biosearch Technologies.
North America was the dominating region in the ribonucleic acid (RNA) isolation and enrichment products market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) isolation and enrichment products market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the ribonucleic acid (RNA) isolation and enrichment products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
This product will be delivered within 3-5 business days.
Table of Contents
Executive Summary
Ribonucleic Acid (RNA) Isolation And Enrichment Products Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses ribonucleic acid (rna) isolation and enrichment products market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for ribonucleic acid (rna) isolation and enrichment products? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ribonucleic acid (rna) isolation and enrichment products market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:
1) By Product Type: Total Ribonucleic Acid Isolation Kits; Messenger Ribonucleic Acid Enrichment Kits; Small Ribonucleic Acid Isolation Kits; Ribonucleic Acid Enrichment Reagents2) By Sample Type: Tissue Samples; Blood Samples; Cell Samples; Microorganism Samples; Other Biological Samples
3) By Workflow Type: Manual Ribonucleic Acid Isolation And Enrichment; Semi Automated Ribonucleic Acid Isolation And Enrichment; Fully Automated Ribonucleic Acid Isolation And Enrichment
4) By Application: Gene Expression Analysis; Next Generation Sequencing; Drug Discovery And Development; Biomarker Discovery; Clinical Diagnostics
5) By End User: Universities; Research Laboratories
Subsegments:
1) By Total Ribonucleic Acid Isolation Kits: Column Based Total Ribonucleic Acid Isolation Kits; Magnetic Bead Based Total Ribonucleic Acid Isolation Kits; Phenol Chloroform Total Ribonucleic Acid Isolation Kits; Automated Total Ribonucleic Acid Isolation Kits; Manual Total Ribonucleic Acid Isolation Kits; High Purity Total Ribonucleic Acid Isolation Kits; Genomic Deoxyribonucleic Acid Removal Total Ribonucleic Acid Isolation Kits; Tissue Total Ribonucleic Acid Isolation Kits; Cell Total Ribonucleic Acid Isolation Kits; Blood Total Ribonucleic Acid Isolation Kits2) By Messenger Ribonucleic Acid Enrichment Kits: Polyadenylated Ribonucleic Acid Enrichment Kits; Ribosomal Ribonucleic Acid Depletion Kits; Magnetic Bead Messenger Ribonucleic Acid Enrichment Kits; Column Based Messenger Ribonucleic Acid Enrichment Kits; Low Input Messenger Ribonucleic Acid Enrichment Kits; Sequencing Library Preparation Messenger Ribonucleic Acid Enrichment Kits; Transcriptome Analysis Messenger Ribonucleic Acid Enrichment Kits; Cell Free Messenger Ribonucleic Acid Enrichment Kits; High Sensitivity Messenger Ribonucleic Acid Enrichment Kits; Automated Messenger Ribonucleic Acid Enrichment Kits
3) By Small Ribonucleic Acid Isolation Kits: Micro Ribonucleic Acid Isolation Kits; Transfer Ribonucleic Acid Isolation Kits; Small Interfering Ribonucleic Acid Isolation Kits; Piwi Interacting Ribonucleic Acid Isolation Kits; Exosomal Small Ribonucleic Acid Isolation Kits; Serum Small Ribonucleic Acid Isolation Kits; Plasma Small Ribonucleic Acid Isolation Kits; Magnetic Bead Small Ribonucleic Acid Isolation Kits; Column Based Small Ribonucleic Acid Isolation Kits; High Yield Small Ribonucleic Acid Isolation Kits
4) By Ribonucleic Acid Enrichment Reagents: Ribosomal Ribonucleic Acid Depletion Reagents; Messenger Ribonucleic Acid Capture Reagents; Transcript Enrichment Reagents; Magnetic Bead Enrichment Reagents; Complementary Deoxyribonucleic Acid Synthesis Reagents; Library Preparation Enrichment Reagents; Sequencing Workflow Enrichment Reagents; Low Input Ribonucleic Acid Enrichment Reagents; Cell Free Ribonucleic Acid Enrichment Reagents; High Sensitivity Ribonucleic Acid Enrichment Reagents
Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Merck KGaA; Agilent Technologies Inc.; Cytiva; Sartorius AG; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Promega Corporation; Takara Bio Inc.; MP Biomedicals LLC; Analytik Jena GmbH+Co. KG; Macherey-Nagel GmbH & Co. KG; New England Biolabs Inc.; Zymo Research Corporation; Bioneer Corporation; Yeasen Biotechnology (Shanghai) Co. Ltd.; TianGen Biotech (Beijing) Co. Ltd.; Geneaid Biotech Ltd.; HiMedia Laboratories Pvt. Ltd.; Norgen Biotek Corp.; Vazyme Biotech Co. Ltd.; Illumina Inc.; Pacific Biosciences of California Inc.; 10x Genomics Inc.; Revvity Inc.; LGC Biosearch Technologies
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentations: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
- F. Hoffmann-La Roche Ltd.
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Agilent Technologies Inc.
- Cytiva
- Sartorius AG
- Bio-Rad Laboratories Inc.
- QIAGEN N.V.
- Promega Corporation
- Takara Bio Inc.
- MP Biomedicals LLC
- Analytik Jena GmbH+Co. KG
- Macherey-Nagel GmbH & Co. KG
- New England Biolabs Inc.
- Zymo Research Corporation
- Bioneer Corporation
- Yeasen Biotechnology (Shanghai) Co. Ltd.
- TianGen Biotech (Beijing) Co. Ltd.
- Geneaid Biotech Ltd.
- HiMedia Laboratories Pvt. Ltd.
- Norgen Biotek Corp.
- Vazyme Biotech Co. Ltd.
- Illumina Inc.
- Pacific Biosciences of California Inc.
- 10x Genomics Inc.
- Revvity Inc.
- LGC Biosearch Technologies

